China SXT Pharmaceuticals, Inc. - Common Stock (SXTC)
4.5100
+0.0100 (0.22%)
China Sxt Pharmaceuticals Inc is a pharmaceutical company that focuses on the development, manufacturing, and marketing of traditional Chinese medicine products
The company aims to harness the therapeutic potential of herbal formulas and integrative approaches to health, catering to both domestic and international markets. With a commitment to innovation, China Sxt Pharmaceuticals combines traditional medical practices with modern pharmaceutical techniques to enhance the efficacy and safety of its products, while also working to expand its portfolio and distribution channels within the healthcare sector.

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Via Chartmill · February 25, 2025

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Via Chartmill · February 25, 2025

Traders are paying attention to the gapping stocks in Tuesday's session. Let's dive into which stocks are experiencing notable gaps.
Via Chartmill · February 25, 2025

As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · February 24, 2025

Wondering what's happening in Wednesday's pre-market session? Find an overview in this article.
Via Chartmill · February 5, 2025

After the conclusion of the US market's regular session on Friday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via Chartmill · January 24, 2025

Via Benzinga · December 31, 2024

Via Benzinga · December 26, 2024

Via Benzinga · December 10, 2024

Via Benzinga · December 9, 2024

Via Benzinga · September 11, 2024

Although Regencell Bioscience likely skyrocketed on its novel traditional therapeutics approach, RGC stock is highly speculative.
Via InvestorPlace · July 23, 2024

Via Benzinga · July 12, 2024

Via Benzinga · July 12, 2024

Via Benzinga · May 17, 2024

Via Benzinga · April 18, 2024

Shares of The Travelers Companies, Inc. (NYSETRV) fell sharply during Wednesday’s session following first-quarter earnings.
Via Benzinga · April 17, 2024

Via Benzinga · April 17, 2024

Via Benzinga · April 17, 2024

Shares of INVO Bioscience, Inc. (NASDAQINVO) rose sharply in today’s pre-market trading after reporting fourth-quarter results.
Via Benzinga · April 17, 2024

Via Benzinga · April 16, 2024

Shares of Skillsoft Corp. (NASDAQSKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates.
Via Benzinga · April 16, 2024